Literature DB >> 2358563

Urapidil-induced increase of the intracranial pressure in head-trauma patients.

G Singbartl1, G Metzger.   

Abstract

This report deals with two patients suffering from a closed head injury who demonstrated a rise of intracranial pressure (ICP) after bolus injections of urapidil to control arterial hypertension. The rapid fall of the arterial pressure was accompanied by an increase of ICP that amounted to approximately 50% to 100% of the initial values (and thereby reaching ICP values between 32.5 and 40 mmHg); cerebral perfusion pressure decreased to less than 50 mmHg, and nearly reached control values at 15 min after administration of urapidil. The mechanism for this ICP rise is unknown and remains speculative. So far, no other clinical or experimental data are known to us reporting a urapidil induced increase of ICP in head trauma patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2358563     DOI: 10.1007/bf01705166

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  7 in total

1.  Intracranial pressure in the cat during nitroglycerin-induced hypotension.

Authors:  M C Rogers; C Hamburger; K Owen; M H Epstein
Journal:  Anesthesiology       Date:  1979-09       Impact factor: 7.892

Review 2.  Haemodynamic effects of urapidil in arterial hypertension and congestive heart failure.

Authors:  F H Messerli
Journal:  Drugs       Date:  1988       Impact factor: 9.546

3.  A paradoxical cerebral hemodynamic effect of hydralazine.

Authors:  J Overgaard; E Skinhoj
Journal:  Stroke       Date:  1975 Jul-Aug       Impact factor: 7.914

4.  Diffuse cerebral swelling following head injuries in children: the syndrome of "malignant brain edema".

Authors:  D A Bruce; A Alavi; L Bilaniuk; C Dolinskas; W Obrist; B Uzzell
Journal:  J Neurosurg       Date:  1981-02       Impact factor: 5.115

5.  Comparison of phentolamine and urapidil in controlling acute intra-operative hypertension in patients subjected to coronary artery bypass surgery.

Authors:  W Hess; U Schulte-Sasse; J Tarnow; S Veit
Journal:  Eur J Anaesthesiol       Date:  1985-03       Impact factor: 4.330

6.  The influence of urapidil, a new antihypertensive agent, on cerebral perfusion pressure in dogs with and without intracranial hypertension.

Authors:  H Van Aken; C Puchstein; C Anger; P Lawin
Journal:  Intensive Care Med       Date:  1983       Impact factor: 17.440

7.  Urapidil and some analogues with hypotensive properties show high affinities for 5-hydroxytryptamine (5-HT) binding sites of the 5-HT1A subtype and for alpha 1-adrenoceptor binding sites.

Authors:  G Gross; G Hanft; N Kolassa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-12       Impact factor: 3.000

  7 in total
  4 in total

1.  Urapidil-induced raised intracranial pressure.

Authors:  H Van Aken; J Van Hemelrijk
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

2.  Influence of urapidil on cerebrospinal fluid pressure in humans with uncompromised intracranial compliance.

Authors:  C Hörmann; G Luz; J Langmayr; S Schalow; A Benzer
Journal:  Intensive Care Med       Date:  1995-10       Impact factor: 17.440

Review 3.  Urapidil. A reappraisal of its use in the management of hypertension.

Authors:  M Dooley; K L Goa
Journal:  Drugs       Date:  1998-11       Impact factor: 9.546

Review 4.  Calcium Channel Blockers in Acute Care: The Links and Missing Links Between Hemodynamic Effects and Outcome Evidence.

Authors:  Jin Wang; David L McDonagh; Lingzhong Meng
Journal:  Am J Cardiovasc Drugs       Date:  2021-01       Impact factor: 3.571

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.